UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Total revenue	$ 681.9	$ 588.4	$ 1,367.2	$ 1,183.4
Total cost of revenue	341.4	290.2	667.0	578.9
Gross profit	340.5	298.2	700.2	604.5
Operating expenses:
Selling, general and administrative	177.9	152.2	340.6	297.9
Research and development	71.0	59.6	140.0	116.2
Other charges, net	5.4	12.5	10.7	20.0
Total operating expenses	254.3	224.3	491.3	434.1
Operating income	86.2	73.9	208.9	170.4
Interest and other income (expense), net	(8.7)	(4.3)	(24.8)	(6.8)
Income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries	77.5	69.6	184.1	163.6
Income tax provision	19.9	19.9	49.8	51.8
Equity in income of unconsolidated investees, net of tax	0.2	0.0	0.9	0.0
Consolidated net income	57.8	49.7	135.2	111.8
Net income attributable to noncontrolling interests in consolidated subsidiaries	0.7	0.2	1.6	0.7
Net income attributable to Bruker Corporation	$ 57.1	$ 49.5	$ 133.6	$ 111.1
Net income per common share attributable to Bruker Corporation shareholders:
Basic	$ 0.39	$ 0.33	$ 0.91	$ 0.74
Diluted	$ 0.39	$ 0.33	$ 0.91	$ 0.74
Weighted average common shares outstanding:
Basic	146.8	149	146.8	149.7
Diluted	147.7	149.8	147.6	150.6
Comprehensive income	$ 52.9	$ 15.9	$ 145.5	$ 69.1
Less: Comprehensive income (loss) attributable to noncontrolling interests	1.3	(0.4)	2.6	(0.2)
Less: Comprehensive loss attributable to redeemable noncontrolling interest	(0.3)	(0.5)	(0.3)	(0.7)
Comprehensive income attributable to Bruker Corporation	51.9	16.8	143.2	70.0
Product
Total revenue	559.6	485.8	1,126.7	976.2
Total cost of revenue	272.8	230.1	530.0	459.1
Other
Total revenue	122.3	102.6	240.5	207.2
Total cost of revenue	$ 68.6	$ 60.1	$ 137.0	$ 119.8